AnaptysBio, Inc.
ANAB
$20.63
$0.271.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -19.83% | -35.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -19.83% | -35.59% | |||
| Cost of Revenue | -8.15% | -3.31% | |||
| Gross Profit | -16.05% | -2,658.97% | |||
| SG&A Expenses | -24.92% | 38.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.43% | 4.79% | |||
| Operating Income | 4.97% | -184.79% | |||
| Income Before Tax | 1.77% | -80.29% | |||
| Income Tax Expenses | -11.36% | 833.33% | |||
| Earnings from Continuing Operations | 1.78% | -80.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.78% | -80.54% | |||
| EBIT | 4.97% | -184.79% | |||
| EBITDA | 4.98% | -187.59% | |||
| EPS Basic | -4.48% | -79.40% | |||
| Normalized Basic EPS | -4.49% | -79.12% | |||
| EPS Diluted | -4.48% | -79.40% | |||
| Normalized Diluted EPS | -4.49% | -79.12% | |||
| Average Basic Shares Outstanding | -5.98% | 0.64% | |||
| Average Diluted Shares Outstanding | -5.98% | 0.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||